Skip to main navigation Skip to search Skip to main content

Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

  • Kambiz Rahbar
  • , Markus Essler
  • , Kim M. Pabst
  • , Matthias Eiber
  • , Christian la Fougère
  • , Vikas Prasad
  • , Philipp Rassek
  • , Ergela Hasa
  • , Helmut Dittmann
  • , Ralph A. Bundschuh
  • , Wolfgang P. Fendler
  • , Milena Kurtinecz
  • , Anja Schmall
  • , Frank Verholen
  • , Oliver Sartor

Research output: Contribution to journal › Article › peer-review

34   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry